Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new phase of the Cancer Moonshot to end cancer as we know it
Dinah S. Singer
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1345-1347
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Artificial intelligence for digital and computational pathology
Andrew H. Song, Guillaume Jaume, Drew F. K. Williamson, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 12, pp. 930-949
Closed Access | Times Cited: 84
Advances in cutaneous squamous cell carcinoma
M.C.G. Winge, Laura N. Kellman, Konnie Guo, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 430-449
Closed Access | Times Cited: 59
Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047
Meredith S. Shiels, Stanley Lipkowitz, Nicole G. Campos, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1084-1099
Open Access | Times Cited: 30
Emerging technologies for cancer therapy using accelerated particles
Christian Graeff, Lennart Volz, Marco Durante
Progress in Particle and Nuclear Physics (2023) Vol. 131, pp. 104046-104046
Open Access | Times Cited: 28
Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer
Wenjie Shi, Thomas Wartmann, Sara Accuffi, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 1, pp. 125-134
Open Access | Times Cited: 27
Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
Cambridge Prisms Precision Medicine (2024) Vol. 2
Open Access | Times Cited: 8
Impact of Prior Authorization on Patient Access to Cancer Care
Dario Trapani, Lianne Kraemer, Hope S. Rugo, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Open Access | Times Cited: 12
Predictors of colorectal cancer screening and screening modalities among patients seen at federally qualified health Centers funded by the United States Health Resources and Services Administration
M. Aaronson, Nadereh Pourat, Connie Lu, et al.
Preventive Medicine Reports (2025) Vol. 50, pp. 102976-102976
Open Access
Rare cancer survivorship research funding at the National Institutes of Health (NIH), 2017 to 2023
Lisa Gallicchio, Michelle Mollica, G Tesauro, et al.
Cancer Causes & Control (2025)
Open Access
Shooting for the Moon: Can We Cut Cancer Mortality in Canada By 50% By 2050?
Keaton Banik, Yibing Ruan, Mariet Mathew Stephen, et al.
Cancer Control (2025) Vol. 32
Open Access
Barriers and Enablers to Cancer Prevention, Screening and Early Detection Among Travellers in Ireland: Healthcare Professionals Perspectives
Patricia Fox, R Jalal, Regina Joye, et al.
Seminars in Oncology Nursing (2025), pp. 151889-151889
Open Access
Absolute lung cancer risk increases among individuals with >15 quit‐years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines
Rebecca Landy, Li C. Cheung, Corey D. Young, et al.
Cancer (2023) Vol. 130, Iss. 2, pp. 201-215
Open Access | Times Cited: 9
Mitigating Cancer Disparities Through an Innovative Navigation Program
Carla Strom, Emily Copus, Karen M. Winkfield
North Carolina Medical Journal (2024) Vol. 85, Iss. 1
Open Access | Times Cited: 2
Clinical Trials—Real-World Data to Build a Future for Our Patients
Catherine C. Fahey, W. Kimryn Rathmell
Journal of Clinical Oncology (2024) Vol. 42, Iss. 18, pp. 2117-2120
Closed Access | Times Cited: 2
National Cancer Institute-funded grants focused on synchronous telehealth cancer care delivery: a portfolio analysis
Roxanne E. Jensen, Rachelle Brick, Joshua Medel, et al.
JNCI Monographs (2024) Vol. 2024, Iss. 64, pp. 55-61
Open Access | Times Cited: 2
Accelerating Progress to Reduce the Cancer Burden through Prevention and Control in the US
Katrina A.B. Goddard, Eric J. Feuer, Asad Umar, et al.
JNCI Journal of the National Cancer Institute (2024)
Open Access | Times Cited: 2
The Cancer Moonshot, the role of in vitro models, model accuracy, and the need for validation
Peter C. Searson
Nature Nanotechnology (2023) Vol. 18, Iss. 10, pp. 1121-1123
Closed Access | Times Cited: 6
The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors
Sara Piccinelli, Rizwan Romee, Roman M. Shapiro
Seminars in Hematology (2023) Vol. 60, Iss. 1, pp. 42-51
Closed Access | Times Cited: 5
Vaccines for cancer prevention: exploring opportunities and navigating challenges
Michele Graciotti, Lana E. Kandalaft
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 1
Mobile Health Solutions for Prostate Cancer Diagnostics—A Systematic Review
Masood Moghul, Walter Cazzaniga, Fionnuala Croft, et al.
Clinics and Practice (2023) Vol. 13, Iss. 4, pp. 863-872
Open Access | Times Cited: 2
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
Brian J. Thomas, Sania Zafar Awan, Trupti Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Author comment: Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm — R1/PR4
Bass Hassan
(2024)
Open Access
Decision: Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm — R1/PR6
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
(2024)
Open Access
Recommendation: Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm — R0/PR2
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
(2024)
Open Access
Recommendation: Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm — R1/PR5
Nesrine Lajmi, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, et al.
(2024)
Open Access
Page 1 - Next Page

Scroll to top